Monopar Therapeutics (MNPR) Return on Assets (2018 - 2025)

Monopar Therapeutics (MNPR) has 8 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Assets climbed to 0.0% in Q4 2025, from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.02% in Q3 2023.
• A 5-year average of 0.01% and a median of 0.01% in 2024 frame the typical range for Return on Assets.
• Across the five-year window, Return on Assets fell 1 bps in 2022 and grew 1 bps in 2023, its largest moves.
• Tracing MNPR's Return on Assets over 5 years: stood at 0.01% in 2021, then sank by 95 bps to 0.02% in 2022, then soared by 44 bps to 0.01% in 2023, then jumped by 82 bps to 0.0% in 2024, then jumped by 53 bps to 0.0% in 2025.
• Business Quant data shows MNPR's Return on Assets at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.